A cross-sectional study of 54 HIV-positive adults with type 2 diabetes at Uganda's Lira Regional Referral Hospital finds that glycemic control varies significantly across non-dolutegravir antiretroviral regimens, with the best outcomes in patients on TDF/3TC/EFV plus metformin alone.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.